CHEMOS
LNP - Laboratory

LNP

产品展示

产品编号名称CAS号结构式分子量购买
CH51001β-Sitosterol83-46-5
β-Sitosterol structure, CAS 83-46-5, MW 414.72
414.72
CH51002Potassium Sucrose Octasulfate73264-44-5
Potassium Sucrose Octasulfate structure, CAS 73264-44-5, MW 1287.52
1287.52
CH51003DLin-MC3-DMA1224606-06-7
DLin-MC3-DMA structure, CAS 1224606-06-7, MW 642.09
642.09
CH51004DPPC63-89-8
DPPC structure, CAS 63-89-8, MW 734.04
734.04
CH51005DSPC816-94-4
DSPC structure, CAS 816-94-4, MW 790.15
790.15
CH51006HSPC92128-87-5
HSPC structure, CAS 92128-87-5, MW 762.1
762.1
CH51007L-A-PHOSPHATIDYLINOSITOL97281-52-2
L-A-PHOSPHATIDYLINOSITOL structure, CAS 97281-52-2, MW 867.14
867.14
CH51008M-lysoPC20559-16-4
M-lysoPC structure, CAS 20559-16-4, MW 467.58
467.58
CH51009C12-2001220890-25-4
C12-200 structure, CAS 1220890-25-4, MW 1136.93
1136.93
CH51010ALC-03152036272-55-4
ALC-0315 structure, CAS 2036272-55-4, MW 766.27
766.27
技术咨询

常见问题

LNP相关的定制合成、工艺开发、分析资料与项目沟通问题。

What are the four lipid components of an LNP?
Typical LNP systems contain an ionizable lipid, a helper phospholipid, cholesterol or a sterol analog, and a PEG-lipid. Each component contributes to encapsulation, membrane behavior, particle stability, and formulation performance.
How do I choose between different ionizable lipids?
Selection depends on target payload, tissue objective, formulation compatibility, intellectual-property considerations, and the intended research workflow. Many projects compare several ionizable lipids and related analogs before selecting a lead formulation component.
What scale of LNP lipids can CHEMOS support?
CHEMOS can review custom synthesis, route development, and scale-up requirements according to the target structure and requested specification. Availability, batch size, and documentation should be confirmed with the sales and technical teams for each project.
How are unsaturated lipids handled?
Unsaturated lipids are reviewed for oxidation sensitivity, packaging requirements, and storage conditions. Inert-atmosphere handling or low-temperature shipment can be discussed when appropriate for the compound form.
Can CHEMOS provide technical documentation for LNP lipid projects?
Batch-specific COA and relevant technical information are provided according to the confirmed specification. Additional documentation requirements can be discussed during project review.

联系我们

让创新连接，让合作发生

无论您处于早期研发、路线探索、工艺开发还是项目放大阶段，CHEMOS始终以有机合成能力、研发团队和生产基地为支撑，为您提供高效、可靠的定制合成解决方案。

* 必填字段